In addition, it was identified that hsa-miR-125b-5p, as a T-cell suppressor, had an increasing trend in the PD group at baseline and was significantly decreased in plasma EVs of PR patients after treatments [41] .
← all excerpts
Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy.
1
—
—